Hexarelin Research Peptide: Complete Guide to Mechanism, Studies, and Lab Applications
Research Use Only: Hexarelin is not approved by the FDA for human or veterinary use. Sold exclusively as a research compound for licensed laboratory settings. Nothing here constitutes medical advice.
Hexarelin is a synthetic, six-amino-acid growth hormone-releasing peptide (GHRP) studied extensively in preclinical research for its ability to stimulate growth hormone release via the GHS-R1a receptor — the same receptor activated by ghrelin. It is one of the most potent synthetic GHRPs documented in animal research, and has been studied across somatotropic axis biology, cardiovascular tissue, and metabolic function. Researchers can source Hexarelin from Palmetto Peptides with ≥98% HPLC purity and full lot-specific CoA documentation.
Background and Development
Hexarelin emerged from structure-activity relationship work aimed at optimizing the GHRP-6 scaffold. The key modification — substituting D-tryptophan at position 2 with D-2-methyltryptophan — increased GHS-R1a binding affinity, improved metabolic stability, and produced more potent GH-releasing responses in preclinical models. By the mid-1990s, hexarelin had been characterized in rodent models, non-human primates, and limited early-phase pharmacokinetic studies.
Molecular Structure
Sequence: His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH₂ | MW: ~887.0 g/mol | CAS: 140703-51-1 | Receptor: GHS-R1a (full agonist). Contains two D-amino acids critical for receptor geometry and enzymatic resistance. The C-terminal amide contributes to receptor binding and plasma stability.
Mechanism of Action: GHS-R1a Signaling
Hexarelin binds GHS-R1a, a Gq/11-coupled GPCR expressed in pituitary somatotrophs, hypothalamus, cardiac tissue, and peripheral organs. Binding triggers: (1) Gq/11 activation → (2) PLCβ stimulation → (3) IP3-mediated calcium release from endoplasmic reticulum → (4) GH vesicle exocytosis. GH peaks 15–30 min post-administration in rodent models and returns to baseline by 90–120 min. Hexarelin also modulates hypothalamic somatostatin tone and exerts GH-independent effects in cardiac tissue via peripheral GHS-R1a receptors.
Preclinical Research Findings
- GH secretion: Robust, dose-dependent GH pulses — among the largest for any synthetic GHRP in rodent models
- IGF-1 axis: Sustained protocols document measurable IGF-1 elevation, especially in GH-deficient animal models
- Cardiac tissue: GH-independent GHS-R1a activity in cardiomyocytes documented; findings in ischemic cardiac models in animals
- Adrenocortical: Modest ACTH/cortisol elevation alongside GH response — distinguishes hexarelin from ipamorelin
- Metabolic: Body composition observations in GH-deficient rodent models, primarily downstream of GH activation
Hexarelin vs. Related GHRPs
| Compound | GH Potency | Selectivity | Desensitization | Cardiac Research |
|---|---|---|---|---|
| Hexarelin | Very High | Broad | Pronounced | Extensive |
| Ipamorelin | Moderate | High (GH-selective) | Low | Limited |
| GHRP-6 | Moderate-High | Moderate | Moderate | Limited |
| CJC-1295 | High (GHRH axis) | High | Low | Minimal |
Protocol Considerations
Doses in literature: 50–300 mcg/kg rodent; most GH response studies use 100–200 mcg/kg SC. Receptor desensitization is the critical protocol variable — twice-daily dosing for 1–4 weeks produces significant GH attenuation. Researchers use intermittent schedules (every other day or 3×/week), washout periods, and baseline/endpoint GH measurements. GH peak sampling window: 15–30 min post-dose.
Storage and Reconstitution
Lyophilized: stable 12–24 months at -20°C in sealed desiccated vials away from light. Reconstitute with bacteriostatic water — add solvent gently along vial wall, swirl (do not vortex). Reconstituted: stable up to 30 days at 2–8°C with BAC water. Aliquot and store at -80°C for extended use. Avoid freeze-thaw cycling.
Quality Standards for Research Sourcing
Minimum ≥95% HPLC purity for in vitro work; ≥98% preferred for in vivo animal studies. CoA must include MS identity confirmation (~887.0 g/mol), HPLC chromatogram, and endotoxin testing data for in vivo applications. Palmetto Peptides Hexarelin is third-party verified with full lot-specific documentation. Use the Reconstitution Calculator for working concentration prep.
Cluster Articles
- What Is Hexarelin? Mechanism of Action Explained
- Hexarelin vs. Ipamorelin: Research Comparison
- Hexarelin Dosage Protocols in Research Settings
- Hexarelin Half-Life and Stability
- How Hexarelin Interacts with GHS-R1a
- Hexarelin Research Benefits: Published Study Review
- Hexarelin Side Effects: Research Safety Profile
- Hexarelin Storage Guidelines for Research Labs
- Hexarelin and IGF-1 Response
- Where to Buy Hexarelin for Research
- Hexarelin vs. GHRP-6
- Hexarelin Synthesis and Manufacturing